311
Views
9
CrossRef citations to date
0
Altmetric
Clinical Focus: Allergies, Autoimmune Disease and Immunizations - Original Research

Barriers of vaccinations against serious bacterial infections among Australian Hajj pilgrims

, , , , , , , & show all
Pages 541-547 | Received 18 Mar 2016, Accepted 17 May 2016, Published online: 09 Jun 2016

References

  • Australian Government Department of Health. The Australian Immunisation Handbook 2013 [cited 2016 May 2]. 10th ed. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/7B28E87511E08905CA257D4D001DB1F8/$File/Aus-Imm-Handbook.pdf.
  • McBride WJ. Infections in travellers arriving from Australia. Trans R Soc Trop Med Hyg. 2008;102(4):312–313.
  • Hill DR. Advising the traveller. Medicine. 2005;33(7):1–3.
  • Alqarni H, Memish ZA, Assiri AM. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj) – 2015. J Epidemiol Glob Health. 2016;6(1):7–9.
  • Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, et al. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Med Infect Dis. 2013;11(5):288–294.
  • Memish ZA, Assiri A, Almasri M, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis. 2014;210(7):1067–1072.
  • Alfelali M, Barasheed O, Tashani M, et al. Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: a 10-year retrospective analysis of data. Vaccine. 2015;33(22):2562–2569.
  • Keles H, Sonder GJB, Van Den Hoek A. Predictors for the uptake of recommended vaccinations in Mecca travelers who visited the public health service Amsterdam for mandatory meningitis vaccination. J Travel Med. 2011;18(3):198–202.
  • Gautret P, Parola P, Brouqui P. Vaccination acceptability in Hajj pilgrims. J Travel Med. 2011;18(3):226.
  • Gautret P, Yong W, Soula G, et al. Determinants of tetanus, diphtheria and poliomyelitis vaccinations among Hajj pilgrims, Marseille, France. Eur J Public Health. 2010;20(4):438–442.
  • Tashani M, Barasheed O, Azeem M, et al. Pneumococcal vaccine uptake among Australian Hajj Pilgrims in 2011–13. Infect Disord Drug Targets. 2014;14(2):117–124.
  • Alqahtani AS, Wiley KE, Tashani M, et al. Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj. Int J Infect Dis. 2016. doi:10.1016/j.ijid.2016.02.005. [Epub ahead of print].
  • Ridda I, Macintyre CR, Lindley RI. A qualitative study to assess the perceived benefits and barriers to the pneumococcal vaccine in hospitalised older people. Vaccine. 2009;27(28):3775–3779.
  • Sharma H, Parekh S, Shewale S. Travel vaccination. J Vaccines Immun. 2015;1(1):009–10.
  • Hull B, Dey A, Campbell-Lloyd S, et al. NSW annual immunisation coverage report, 2011. N S W Public Health Bull. 2012;23(9–10):179–186.
  • Gautret P, Vu Hai V, Sani S, et al. Protective measures against acute respiratory symptoms in French pilgrims participating in the Hajj of 2009. J Travel Med. 2011;18(1):53–55.
  • Gautret P, Bauge M, Simon F, et al. Pneumococcal vaccination and Hajj. Int J Infect Dis. 2011;15(10):e730.
  • Benkouiten S, Gautret P, Belhouchat K, et al. Acquisition of streptococcus pneumoniae carriage in pilgrims during the 2012 Hajj. Clin Infect Dis. 2014;58(4):e106–9.
  • Benkouiten S, Charrel R, Belhouchat K, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20(11):1821–1827.
  • Meysamie A, Ardakani HZ, Razavi SM, et al. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med J. 2006;27(7):1049–1053.
  • Shafi S, Rashid H, Ali K, et al. Influenza vaccine uptake among British Muslims attending Hajj, 2005 and 2006. Bmj. 2006;333(7580):1220.
  • Hashim S, Ayub ZN, Mohamed Z, et al. The prevalence and preventive measures of the respiratory illness among Malaysian pilgrims in 2013 hajj season. J Travel Med. 2016;23(2):tav019.
  • Gautret P, Gaillard C, Soula G, et al. Pilgrims from Marseille, France, to Mecca: demographics and vaccination status. J Travel Med. 2007;14(2):132–133.
  • Ridda I, Gao Z, Macintyre CR. Attitudes, knowledge and perceptions towards whooping cough and pertussis vaccine in hospitalized adults. Vaccine. 2014;32(9):1107–1112.
  • Motbey C. Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach. Hum Vaccin. 2008;4(5):341–343.
  • Zimmerman RK, Santibanez TA, Fine MJ, et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine. 2003;21(13–14):1510–1517.
  • Greenhalgh T. Time for patient leaflets on the Hajj. Bmj. 2011;343:d6609.
  • Sulaiman K-D. An assessment of Muslims reactions to the children immunization in Northern Nigeria. Inter J Humanities & Religion. 2014;2(6):137–147.
  • Larson H, Leask J, Aggett S, et al. A multidisciplinary research agenda for understanding vaccine-related decisions. Vaccines (Basel). 2013;1(3):293–304.
  • Syafinaz Amin N, Faridah I, Rukman AH, et al. Parental refusal to diphtheria vaccine: a fatal outcome. Med J Malaysia. 2013;68(5):435–436.
  • World Health Organization Regional Office for the Eastern Mediterranean. Statement arising from a seminar held by the Islamic Organization for Medical Sciences on ‘The judicially prohibited and impure substances in foodstuff and drugs’ 2001. Available from: http://www.immunize.org/concerns/porcine.pdf.
  • Provost S, Soto JC. Predictors of pretravel consultation in tourists from Quebec (Canada). J Travel Med. 2001;8(2):66–75.
  • Barasheed O, Rashid H, Heron L, et al. Influenza vaccination among Australian Hajj pilgrims: uptake, attitudes, and barriers. J Travel Med. 2014;21(6):384–390.
  • Crockett M, Keystone J. “I hate needles” and other factors impacting on travel vaccine uptake. J Travel Med. 2005;12:S41–S46.
  • Mollema L, Wijers N, Hahné S, et al. Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires. BMC Public Health. 2012;12(1):57.
  • Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine. 2010;28(26):4235–4248.
  • Gautret P, Soula G, Parola P, et al. Hajj pilgrims’ knowledge about acute respiratory infections. Emerg Infect Dis. 2009;15(11):1861–1862.
  • Memish ZA, Assiri AM, Hussain R, et al. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J Travel Med. 2012;19(1):15–21.
  • Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135(1):139–143.
  • Ridda I, MacIntyre RC, Lindley RI, et al. Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Hum Vaccin. 2007;3(3):83–86.
  • Pobre K, Tashani M, Ridda I, et al. Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines. Vaccine. 2014;32(13):1423–1430.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.